Grasso M, Chalik Y
Department of Urology, New York University Medical Center, New York, NY 10016, USA.
J Clin Laser Med Surg. 1998 Feb;16(1):3-7. doi: 10.1089/clm.1998.16.3.
The initial clinical experience with holmium laser energy applied for endoscopic lithotripsy was positive. The current study is presented as a contrast to the preliminary findings and as a means of defining the clinical usefulness of this specific laser lithotrite.
Calculi were treated endoscopically with the holmium laser lithotriptor and data was gathered prospectively. The youngest patient in the series was a thirteen-month--old who underwent percutaneous therapy, while the youngest patient on whom a retrograde endoscopic procedure was performed was a six-year old male patient with a proximal ureteral calculus. Lower water density, quartz fibers delivery systems were developed and employed. Fiber diameters ranged from 200-1000 micrograms. The smaller fibers were employed most commonly through the actively deflectable, flexible endoscope to facilitate treatment with maximum deflection. Larger fibers, with their much larger vaporization bubbles, were used through rigid endoscopes to debulk large stone burdens.
A total of 210 patients with 249 calculi were treated. All major stone compositions were treated with minimal variation in laser efficiency. All but three of 109 ureteral calculi were treated in a retrograde fashion to completion (i.e., "stone free") in one sitting (97%). One-hundred thirteen renal stone burdens were treated with the holmium laser; 99 of these were treated solely in a retrograde fashion. Of the latter, 79 (80%) required only a single session. The combination of the actively deflectable, flexible ureteroscope and the 200-micrograms fiber facilitated treatment to completion of 38 to 45 lower-pole caliceal calculi (85%). The success of ureteropyeloscopic lithotripsy with the holmium laser for all intrarenal calculi, including staged or second sitting for large complex stone burdens, was 90%. Sixteen percutaneous procedures (13 renal and 3 ureteral calculi) employed the holmium laser as an endoscopic lithotrite. All 28 patients with large bladder calculi with a mean diameter of 41.8 mm were treated to completion in one sitting. Complications from holmium laser energy, including postoperative ureteral stricture disease, were not encountered in this series.
Holmium laser energy is uniquely suited to treat urinary calculi safely regardless of stone size, location, or metabolic composition, and has particular efficacy in complex clinical presentations.
钬激光能量应用于内镜下碎石术的初步临床经验是积极的。本研究旨在与初步研究结果形成对比,并确定这种特定激光碎石器的临床实用性。
使用钬激光碎石器对结石进行内镜治疗,并前瞻性收集数据。该系列中最年轻的患者是一名13个月大的儿童,接受了经皮治疗,而接受逆行内镜手术的最年轻患者是一名6岁男性,患有近端输尿管结石。开发并采用了低水密度的石英纤维输送系统。纤维直径范围为200 - 1000微克。较小的纤维最常通过可主动弯曲的柔性内窥镜使用,以在最大弯曲度下便于治疗。较大的纤维,因其产生的汽化气泡大得多,通过刚性内窥镜用于去除较大的结石负荷。
共治疗了210例患者的249颗结石。所有主要结石成分均接受治疗,激光效率变化极小。109颗输尿管结石中,除3颗外,其余均通过逆行方式一次性治疗至结石清除(即“无石”)(97%)。113例肾结石负荷采用钬激光治疗;其中99例仅采用逆行方式治疗。在后者中,79例(80%)仅需单次治疗。可主动弯曲的柔性输尿管镜与200微克纤维的组合有助于完成38至45颗下极肾盏结石的治疗(85%)。钬激光输尿管肾盂镜碎石术对所有肾内结石的成功率,包括对大的复杂结石负荷进行分期或二次治疗,为90%。16例经皮手术(13例肾结石和3例输尿管结石)采用钬激光作为内镜碎石器。所有28例平均直径为41.8毫米的大膀胱结石患者均一次性治疗至结石清除。本系列未出现钬激光能量相关并发症,包括术后输尿管狭窄疾病。
钬激光能量特别适合安全治疗尿路结石,无论结石大小、位置或代谢成分如何,并且在复杂临床表现中具有特殊疗效。